Loading the section…
Up to five U.S. securities side by side.
| Metric | TXG10x Genomics, Inc. |
|---|---|
| Price | 61.85 |
| Change | −11.79 % |
| Return, 1 year | +508.83 % |
| Market capitalisation | 8.8B |
| Price / earnings | — |
| Price / sales | 14.2 |
| Price / book | 10.6 |
| Enterprise value / EBITDA | — |
| Return on equity | −9.10 % |
| Net margin | −12.18 % |
| Revenue, last year | 617M |
| Net income, last year | −75M |
| Revenue growth, year over year | −4.28 % |
| Debt / equity | — |
| Volatility, 30 days | 86.04 % |
| Beta | 2.19 |
| Sector | Health care |
Data: US exchange trading and company filings with the regulator